Skip to main content

Table 3 NAT2 genotype frequency.

From: Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma

NAT2Genotype

Sporadic-CRC

IBD benign

IBD dysplasia/cancer

Controls

Phenotype

 

No.

%

No.

%

No.

%

No.

%

 

NAT2*5B/*6A

26

21.3

85

23.22

5

33.33

54

24.3

Slow

NAT2*4/*5B

22

18

72

19.67

1

6.66

39

17.5

Intermediate

NAT2*5B/*5B

17

13.9

54

14.75

3

20

32

14.4

Slow

NAT2*4/*6A

24

19.7

48

13.11

4

26.66

30

13.5

Intermediate

NAT2*6A/*6A

16

13.2

20

5.46

  

21

9.45

Slow

NAT2*4/*4

3

2.45

26

7.1

  

16

7.2

Rapid

NAT2*6A/*7B

3

2.45

6

1.63

  

3

1.36

Slow

NAT2*5B/*7B

2

1.63

8

2.18

  

5

2.25

Slow

NAT2*5B/*5C

2

1.63

2

0.54

  

4

1.8

Slow

NAT2*5A/*6A

0

0

2

0.54

  

2

0.9

Slow

NAT2*5B/*13

0

0

5

1.36

1

6.66

2

0.9

Intermediate

NAT2*4/*5A

0

0

5

1.36

  

2

0.9

Intermediate

NAT2*4/*7B

2

1.63

5

1.36

1

6.66

2

0.9

Intermediate

NAT2*5C/*6A

0

0

3

0.819

  

2

0.9

Slow

NAT2*5A/*5B

1

0.81

8

2.18

  

1

0.45

Slow

NAT2*5A/*5C

0

0

2

0.54

  

1

0.45

Slow

NAT2*5B/*12A

1

0.81

0

0

  

1

0.45

Intermediate

NAT2*5C/*5C

0

0

1

0.27

  

1

0.45

Slow

NAT2*4/*12A

0

0

0

0

  

1

0.45

Rapid

NAT2*4/*5C

1

0.81

7

1.91

  

1

0.45

Intermediate

NAT2*6A/*12A

0

0

0

0

  

1

0.45

Intermediate

NAT2*6A/*13

1

0.81

1

0.27

  

1

0.45

Intermediate

NAT2*4/*13

0

0

2

0.54

  

0

0

Rapid

NAT2*5A/*13

0

0

1

0.27

  

0

0

Intermediate

NAT2*5A/*5A

1

0.81

1

0.27

  

0

0

Slow

NAT2*5C/*7B

0

0

2

0.54

  

0

0

Slow

Total

122

 

366

 

15

 

222

  
  1. Genotypes listed by order of decreasing frequency in control group
  2. IBD: inflammatory bowel disease
  3. CRC: colorectal cancer